The outcome effect of double-hormonal therapy in premenopausal breast cancer patients with high nodal-status: Result of a prospective randomized trial

Breast Cancer Patients ◽

P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)89301-x ◽

1998 ◽

Vol 34 ◽

pp. S36 ◽

Cited By ~ 3

Author(s):

E. Galligioni ◽

G. Cetto ◽

O. Nascimben ◽

A. Buonadonna ◽

D. Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Adjuvant Chemotherapy ◽

Randomized Trial ◽

Cancer Patients ◽

High Dose ◽

Breast Cancer Patients ◽

Prospective randomized trial comparing postoperative adjuvant concurrent versus sequential hormonal and different radiation fractionation schedule in breast cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.544 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 544-544 ◽

Cited By ~ 4

Author(s):

M. S. Barsoum ◽

M. M. El Mongi ◽

E. M. Khalil ◽

H. E. Eisa ◽

I. M. Hamed ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Fractionation Schedule

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

Breast Cancer Research and Treatment ◽

10.1023/a:1006063412726 ◽

1998 ◽

Vol 49 (3) ◽

pp. 209-217 ◽

Cited By ~ 34

Author(s):

Dino Amadori ◽

Giovanni Luca Frassineti ◽

Andrea De Matteis ◽

Giorgio Mustacchi ◽

Antonio Santoro ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9844-9 ◽

2007 ◽

Vol 112 (2) ◽

pp. 309-316 ◽

Cited By ~ 16

Author(s):

Susanne Taucher ◽

Guenther G. Steger ◽

Raimund Jakesz ◽

Christoph Tausch ◽

Viktor Wette ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Neoadjuvant Chemotherapy ◽

Randomized Trial ◽

Cancer Patients ◽

Potential Risk ◽

Study Group ◽

Breast Cancer Patients ◽

Cancer Study Group

Supplemental Material for A Randomized Trial to Promote Physical Activity Among Breast Cancer Patients

Health Psychology ◽

10.1037/a0029886.supp ◽

2013 ◽

Keyword(s):

Breast Cancer ◽

Physical Activity ◽

Randomized Trial ◽

Cancer Patients ◽

Breast Cancer Patients

Decision letter for "Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen"

10.1002/1878-0261.12865/v1/decision1 ◽

2020 ◽

Keyword(s):

Breast Cancer ◽

Clinical Outcome ◽

Cancer Patients ◽

Early Stage ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Adverse Clinical Outcome ◽

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Case Medical Research ◽

10.31525/ct1-nct03844685 ◽

2000 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Red Clover ◽

Lifestyle Changes ◽

Menopausal Symptoms ◽

Breast Cancer Patients ◽

1967 Does adjuvant chemotherapy induced amenorrhea effect survival in operated premenopausal breast cancer patients?

European Journal of Cancer ◽

10.1016/s0959-8049(16)30915-7 ◽

2015 ◽

Vol 51 ◽

pp. S322-S323

Author(s):

C. Ordu ◽

G. Alço ◽

K.N. Pilanc ◽

S. Ilgün ◽

D. Sarsenov ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

Breast Cancer Research ◽

10.1186/bcr2320 ◽

2009 ◽

Vol 11 (3) ◽

Cited By ~ 19

Author(s):

Christos Markopoulos ◽

Urania Dafni ◽

John Misitzis ◽

Vasilios Zobolas ◽

Evagelos Tzoracoleftherakis ◽

...

Keyword(s):

Breast Cancer ◽

Lipid Profile ◽

Cancer Patients ◽

Hormonal Therapy ◽

Detrimental Effect ◽

Postmenopausal Breast Cancer ◽

Adjuvant Hormonal Therapy ◽

Breast Cancer Patients

PP-8-4 An open, comparative randomized trial comparing formestane vs oral megestrol acetate as a second-line therapy in postmenopausal advanced breast cancer patients

European Journal of Cancer ◽

10.1016/0959-8049(96)84239-0 ◽

1996 ◽

Vol 32 ◽

pp. 49 ◽

Cited By ~ 5

Author(s):

C. Rose ◽

M. Freue ◽

M. Kjaer ◽

C. Boni ◽

F. Jänicke ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Advanced Breast ◽

Megestrol Acetate ◽

Second Line ◽

Breast Cancer Patients ◽

Second Line Therapy ◽

Line Therapy